Thursday, March 16, 2023 episode artwork

EPISODE · Mar 16, 2023 · 6 MIN

Thursday, March 16, 2023

from The Gist Healthcare Podcast

The Biden Administration will fine the drug manufacturers of 27 medicines for sharp price increases. The FDA approves Pfizer’s bivalent COVID booster for children as young as six months. And, the FDA says that Paxlovid is not responsible for rebound infections of COVID-19 ahead of an advisory committee meeting. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

The Biden Administration will fine the drug manufacturers of 27 medicines for sharp price increases. The FDA approves Pfizer’s bivalent COVID booster for children as young as six months. And, the FDA says that Paxlovid is not responsible for rebound infections of COVID-19 ahead of an advisory committee meeting. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

NOW PLAYING

Thursday, March 16, 2023

0:00 6:07

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Gist Healthcare Podcast?

This episode is 6 minutes long.

When was this The Gist Healthcare Podcast episode published?

This episode was published on March 16, 2023.

What is this episode about?

The Biden Administration will fine the drug manufacturers of 27 medicines for sharp price increases. The FDA approves Pfizer’s bivalent COVID booster for children as young as six months. And, the FDA says that Paxlovid is not responsible for rebound...

Can I download this The Gist Healthcare Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!